- Home
- CYD vs OCUL Comparison
CYD vs OCUL Comparison
Compare CYD & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYD | OCUL |
|---|---|---|
| Founded | 1951 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 1998 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CYD | OCUL |
|---|---|---|
| Price | $44.26 | $10.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $60.00 | $22.90 |
| AVG Volume (30 Days) | 240.5K | ★ 7.6M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | $15.94 | $9.35 |
| Revenue Next Year | $7.89 | $92.88 |
| P/E Ratio | $32.71 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $12.66 | $6.23 |
| 52 Week High | $56.55 | $16.44 |
Technical Indicators
Market Signals| Indicator | CYD | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 59.29 |
| Support Level | $34.58 | $10.65 |
| Resistance Level | $45.93 | $12.63 |
| Average True Range (ATR) | 3.17 | 0.75 |
| MACD | -1.29 | 0.40 |
| Stochastic Oscillator | 7.07 | 85.67 |
Price Performance
Historical ComparisonAbout CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.